CRNX - Crinetics Pharmaceuticals, Inc.

QQQ $ 608.45 $ 0.46 (0.08 %)

DIA $ 471.65 $ -2.94 (-0.62 %)

SPY $ 671.62 $ -0.11 (-0.02 %)

TLT $ 88.93 $ -0.51 (-0.57 %)

GLD $ 375.82 $ -6.91 (-1.8 %)

Previous Close

$ 42.67

Open

$ 41.27

Bid

$ 43.27 x 4

Ask

$ 42.97 x 235

Day's Range

$ 41.30 - $ 43.86

52 Week Range

$ 24.10 - $ 60.34

Volume

1,445,443

Average Volume

Market Cap

2.3B

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-27-2025	01-01-1970	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-28-2024	12-31-2023	10-K
9	11-07-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-09-2023	03-31-2023	10-Q
12	02-28-2023	12-31-2022	10-K
13	11-14-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-30-2022	12-31-2021	10-K
17	11-05-2021	09-30-2021	10-Q
18	08-10-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	03-09-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-13-2019	06-30-2019	10-Q
27	05-13-2019	03-31-2019	10-Q
28	03-13-2019	12-31-2018	10-K
29	11-13-2018	09-30-2018	10-Q
30	08-30-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Citizens Maintains Market Outperform on Cr...
11/07/2025 13:43:22

Citizens analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and lowers the...

Crinetics Pharmaceuticals Reports Cash Bal...
11/06/2025 21:41:40

Crinetics Pharmaceuticals Q3 EPS $(1.38) M...
11/06/2025 21:07:37

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Crinetics To Present At North American Neu...
10/23/2025 12:15:54

fastenal-posts-downbeat-earnings-joins-vince-holding-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

Fastenal Posts Downbeat Earnings, Joins Vi...
10/13/2025 12:23:05

Oppenheimer Maintains Outperform on Crinet...
09/30/2025 13:46:14

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

Morgan Stanley Maintains Overweight on Cri...
09/29/2025 17:05:13

Morgan Stanley analyst Jeffrey Hung maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Overweight and raises the pric...

Goldman Sachs Maintains Neutral on Crineti...
09/26/2025 17:07:48

Goldman Sachs analyst Richard Law maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Neutral and raises the price ta...

fda-approves-crinetics-pharmas-first-daily-pill-for-rare-growth-disorder

FDA Approves Crinetics Pharma's First Dail...
09/26/2025 17:07:40

On Thursday, the U.S.

12 Health Care Stocks Moving In Friday's I...
09/26/2025 17:05:59

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The m...

crinetics-pharmaceuticals-blackberry-perpetua-resources-and-other-big-stocks-moving-higher-on-friday

Crinetics Pharmaceuticals, BlackBerry, Per...
09/26/2025 14:23:15

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceutical...

Assessing Crinetics Pharmaceuticals: Insig...
09/26/2025 14:00:57

Throughout the last three months, 4 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ: CRNX), offering a diverse set of...

JMP Securities Maintains Market Outperform...
09/26/2025 12:11:56

JMP Securities analyst Jonathan Wolleben maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Market Outperform and rai...

12 Health Care Stocks Moving In Friday's P...
09/26/2025 12:10:27

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The ...

Trading Halt: Halt status updated at 7:00:...
09/26/2025 11:00:13

Baird Maintains Outperform on Crinetics Ph...
09/26/2025 10:28:09

Baird analyst Brian Skorney maintains Crinetics Pharmaceuticals (NASDAQ: CRNX) with a Outperform and raises the price target...

Crinetics Pharmaceuticals Receives FDA App...
09/25/2025 21:33:34

SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) today announced that the U.S.

Trading Halt: Halted at 5:18:40 p.m. ET - ...
09/25/2025 21:18:44

JP Morgan Maintains Overweight on Crinetic...
09/24/2025 12:36:36

JP Morgan analyst Jessica Fye maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and lowers the price targe...